Cancer in inflammatory bowel disease: An evidence-based analysis and guide for physicians and patients

Gastroenterology Clinics of North America

Volumn 31, Issue 1, 2002, Pages 237-254

  Sharan, Rupam ^a   Schoen, Robert E ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER; CANCER RISK; COLON BIOPSY; COLONOSCOPY; COLORECTAL CANCER; DISEASE DURATION; ENTERITIS; EVIDENCE BASED MEDICINE; FAMILY HISTORY; HUMAN; ONSET AGE; PRACTICE GUIDELINE; REVIEW; RISK MANAGEMENT; COLORECTAL TUMOR; HEALTH SURVEY; RISK FACTOR;

COLONOSCOPY; COLORECTAL NEOPLASMS; EVIDENCE-BASED MEDICINE; HUMANS; INFLAMMATORY BOWEL DISEASES; POPULATION SURVEILLANCE; RISK FACTORS;

EID: 0035986166     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8553(01)00014-0     Document Type: Article

References (85)

1. Primary sclerosing cholangitis: A long-term follow-up study
2. Family history as a risk factor for colorectal cancer in inflammatory bowel disease
3. Cancer prevention strategies in inflammatory bowel disease
4. Cancer risk in patients with inflammatory bowel disease: A population-based study
5. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis?
6. Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: An indication for colectomy
7. Dysplasia surveillance programs
8. Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis
9. Primary sclerosing cholangitis in ulcerative colitis-a risk factor for the development of dysplasia and DNA aneuploidy?
10. The risk of colorectal cancer in ulcerative colitis: An epidemiologic study
11. Cancer surveillance of patients with longstanding ulcerative colitis: A clinical, endoscopical, and histological study
12. Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis
13. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis
14. Clinicopathological characteristics of colorectal carcinoma complicating ulcerative colitis
15. Gastrointestinal tissue diagnosis by laser-induced fluorescence spectroscopy at endoscopy
16. Cancer risk and life expectancy of children with ulcerative colitis
17. Pericholangitis and sclerosing cholangitis are risk factors for dysplasia and cancer in ulcerative colitis
18. Colorectal cancer prevention in ulcerative colitis: A case-control study
19. The risk of colorectal cancer in ulcerative colitis: A meta-analysis
20. Colorectal cancer complicating ulcerative colitis: A review
21. Risk factors and distinguishing features of cancer in IBD
22. Increased risk of large-bowel cancer in Crohn's disease with colonic involvement
23. Ulcerative colitis and colorectal cancer: A population-based study
24. Extracolonic malignancies in inflammatory bowel disease
25. Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis
26. Malignancy in Crohn's disease
27. Intestinal cancer in patients with Crohn's disease: A population study in central Israel
28. Sigmoidoscopy and biopsy in surveillance for cancer in ulcerative colitis
29. Screening and surveillance colonoscopy in chronic Crohn's colitis
30. A prospective study of family history and the risk of colorectal cancer
31. Colorectal cancer (CRC) in ulcerative colitis (UC)-effect of a cancer prevention strategy on survival
32. Colorectal cancer in patients with ulcerative colitis: A population study in central Israel
33. Ulcerative colitis and Crohn's disease: A comparison of the colorectal cancer risk in extensive colitis
34. Epidemiologic aspects of Crohn's disease: A population based study in Olmsted County, Minnesota, 1943-1982
35. A comparison of cancer risk in Crohn's disease and ulcerative colitis
36. Cancer in universal and left-sided ulcerative colitis: Factors determining risk
37. Neoplastic transformation of the pelvic pouch mucosa in patients with ulcerative colitis
38. Mortality in ulcerative colitis
39. Malignancy in Crohn's disease
40. Long term prognosis in ulcerative colitis-based on results from a regional patient group from the county of Copenhagen
41. Risk of cancer in inflammatory bowel disease: Why are the results in the reviewed literature so varied?
42. The prognosis of carcinoma of the colon and rectum complicating ulcerative colitis
43. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings
44. Surveillance in ulcerative colitis: Burdens and benefit: Precancer and cancer in extensive ulcerative colitis: Findings among 401 patients over 22 years
45. Increased risk of cancer in ulcerative colitis: A population-based cohort study
46. Ulcerative colitis practice guidelines in adults
47. Is there an excess risk for colorectal cancer in patients with ulcerative colitis and concomitant primary sclerosing cholangitis? A population based study
48. Colorectal cancer risk and mortality in patients with ulcerative colitis
49. Hazard rates for dysplasia and cancer in ulcerative colitis: Results from a surveillance program
50. Precancer and cancer in extensive ulcerative colitis: Findings among 401 patients over 22 years
51. Cancer risk in patients with inflammatory bowel disease
52. Mucosal dysplasia and DNA content in ulcerative colitis patients with ileorectal anastomosis. Follow-up study in a defined patient group
53. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis
54. Differences in colonic disease activity in patients with ulcerative colitis with and without primary sclerosing cholangitis: A case control study
55. Endoscopic practice at the start of the new millennium
56. Screening by colonoscopy for colonic epithelial dysplasia in inflammatory bowel disease
57. The risk of cancer and dysplasia among ulcerative colitis patients with primary sclerosing cholangitis
58. Cancer in patients with ulcerative colitis
59. Colorectal and extracolonic malignancy in ulcerative colitis
60. Intestinal cancer risk and mortality in patients with Crohn's disease
61. Familial predisposition for colorectal cancer in chronic ulcerative colitis: A case-control study
62. Cancer surveillance in ulcerative colitis
63. Spectroscopic diagnosis of esophageal cancer: New classification model, improved measurement system
64. Endoscopic fluorescence detection of high-grade dysplasia in Barrett's esophagus
65. Survival and cause-specific mortality in inflammatory bowel disease: A population-based cohort study
66. Crohn's disease and cancer: A population-based cohort study
67. Risk factors for colorectal cancer in patients with ulcerative colitis: A case-control study
68. Cancer morbidity in ulcerative colitis
69. Surveillance issues in inflammatory bowel disease: Ulcerative colitis
70. Dysplasia in inflammatory bowel disease: Standardized classification with provisional clinical applications
71. Value of sigmoidoscopy and biopsy in detection of carcinoma and premalignant change in ulcerative colitis
72. Adenocarcinoma in an ileal pouch for ulcerative colitis
73. Surveillance for colonic carcinoma in ulcerative colitis
74. Low incidence of significant dysplasia in a successful endoscopic surveillance program of patients with ulcerative colitis
75. DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis
76. Colonoscopic polypectomy in chronic colitis: Conservative management after endoscopic resection of dysplastic polyps
77. Cancer in Crohn's disease: Dispelling the myths
78. Families at risk for colorectal cancer: Risk assessment and genetic testing
79. Small bowel carcinoma in Crohn's disease: Distinguishing features and risk factors
80. Cancer in the anal canal (transitional zone) after restorative proctocolectomy with stapled ileal pouch-anal anastomosis
81. The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis
82. Distribution of colorectal cancer in patients with and without ulcerative colitis
83. Cancer in an ileoanal reservoir: A new late complication?
84. Crohn's disease and cancer
85. Incidence, risk factors, and treatment of dysplasia in the anal transitional zone after ileal pouch-anal anastomosis